Skip to main content
. 2021 Oct 1;11(10):e046874. doi: 10.1136/bmjopen-2020-046874

Table 2.

Process evaluation timeline POWER@MS2

Category of participants Measurement time points
Screening Baseline
Month v-1 v0 v1 v2 v3 v4 v5 v6 v7 v8 vx
−1 0 3 6 9 12 15 18 21 24 X
Non-participation study centres ×
Centres structures/processes ×
Evaluation neurologists × × ×
Evaluation study nurses × ×
Evaluation trained MS nurse × ×
Non-participation PwMS × (×) (×) (×) (×) (×) (×) (×) (×) (×) (×)
Evaluation PwMS × × × × ×
Evaluation dropouts (×) (×) (×) (×) (×) (×) (×) (×) (×) (×)
Evaluation stakeholders ×

(×), optional visits; MS, multiple sclerosis; PwMS, people with multiple sclerosis; v0, visit directly after enrolment; v-1, visit before enrolment; v1, visit in month 3; v2, visit in month 6; v3, visit in month 9; v4, visit in month 12; v5, visit in month 15; v6, visit in month 18; v7, visit in month 21; v8, visit in month 24; vx, visit after the final participant reaches v4 (all participants, who have not reached v8).